Biogen Pharmachem Industries Ltd

Statement of profit and loss

Parakho has not ingested a filed result for this company on a consolidated basis. When the company files one with the exchange, it appears here automatically.

Earnings call

Biogen Pharmachem Industries Ltd has not filed a concall transcript in the last 4 quarters.

Filings

12 shown · 22 published by the exchange

05 Aug 2026
Filing
Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
05 Aug 2026
Results
Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")
05 Aug 2026
Board meeting
Board Meeting Outcome for Outcome Of Board Meeting Held On 5Th August 2026.
21 Jul 2026
Board meeting
Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.
07 Jul 2026
Filing
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
12 Jun 2026
Insider trading
Closure of Trading Window
23 May 2026
Filing
Compliances-Reg.24(A)-Annual Secretarial Compliance
20 May 2026
Insider trading
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Appears 3 times in the recent filings shown; listed once.
19 May 2026
Insider trading
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
18 May 2026
Filing
Allotment
14 May 2026
Filing
Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
14 May 2026
Results
Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 05 Aug 2026.